NCT06264947

Brief Summary

This study is to see if laser acupuncture is a better way to treat dry-AMD (Age-related Macular Degeneration) compared to sham laser acupuncture, in the aspect of visual acuity. Investigators planed to recruit participants who are diagnosed with dry-AMD, and not younger than 20 years old. Before the study, investigators will measure the participants' BCVA (Best Corrected Visual Acuity), and then practice laser acupuncture and sham-laser acupuncture on experiment group and control group respectively. After the 4-week study, investigators will measure the participants' BCVA again.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 26, 2024

Completed
11 days until next milestone

First Submitted

Initial submission to the registry

February 6, 2024

Completed
14 days until next milestone

First Posted

Study publicly available on registry

February 20, 2024

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2024

Completed
Last Updated

February 20, 2024

Status Verified

February 1, 2024

Enrollment Period

9 months

First QC Date

February 6, 2024

Last Update Submit

February 15, 2024

Conditions

Keywords

Laser AcupunctureAcupunctureAge-related Macular DegenerationRandomized Controlled Trials

Outcome Measures

Primary Outcomes (1)

  • BCVA (Best Corrected Visual Acuity)

    BCVA is the best possible vision an eye can see with corrective lenses. The gold standard for measuring BCVA is with the Early Treatment Diabetic Retinopathy (ETDRS) chart. The ETDRS score is calculated as the total number of letters correctly read at 4m from the chart plus 30 (if 20 or more letters can be read at 4m). If fewer than 20 letters can be read at 4m, the patient's position is adjusted to 1m in front of the chart.

    "baseline (pre-intervention)", and "immediately after the intervention"

Study Arms (2)

laser acupuncture group

EXPERIMENTAL

3 minutes for each time, and 3 times per week, with duration of 4 weeks

Device: laser acupuncture

sham laser acupuncture group

SHAM COMPARATOR

3 minutes for each time, and 3 times per week, with duration of 4 weeks

Device: sham laser acupuncture

Interventions

wavelength: 808nm energy: 18j power: 100mw

laser acupuncture group

wavelength: 0nm energy: 0j power: 0mw

sham laser acupuncture group

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Those who have been diagnosed with dry-AMD
  • Male or female patients above 20 years of age at the screening visit
  • Those who voluntarily signed the informed consent

You may not qualify if:

  • Those who refuse to sign the consent form
  • Pregnant women
  • Individuals with epilepsy
  • Patients with angina
  • Individuals with hyperthyroidism
  • Patients with a cardiac pacemaker
  • Those who applied immunosuppressive agents containing Arsenic

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

China Medical University Hospital

Taichung, 404, Taiwan

Location

MeSH Terms

Conditions

Macular Degeneration

Condition Hierarchy (Ancestors)

Retinal DegenerationRetinal DiseasesEye Diseases

Study Officials

  • Yu-Chen Lee, M.D. & Ph.D.

    China Medical University Hospital

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
director of department of acupuncture

Study Record Dates

First Submitted

February 6, 2024

First Posted

February 20, 2024

Study Start

January 26, 2024

Primary Completion

November 1, 2024

Study Completion

November 1, 2024

Last Updated

February 20, 2024

Record last verified: 2024-02

Locations